title: Could trastuzumab suppress hepatitis C virus in a patient with chronic hepatitis and breast cancer?
authors: Akihiro
authors: A
authors: Tamori
authors: Hidemi
authors: H
authors: Kawajiri
authors: Tsutomu
authors: T
authors: Takashima
authors: Hiroyuki
authors: H
authors: Motoyama
authors: Hiroyasu
authors: H
authors: Morikawa
authors: Masaru
authors: M
authors: Enomoto
authors: Kosei
authors: K
authors: Hirakawa
authors: Norifumi
authors: N
authors: Kawada
mesh_terms: D000368:Aged; D000730:Androstadienes / Q000008:administration & dosage; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology*; D015415:Biomarkers / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D004338:Drug Combinations; D066246:ErbB Receptors / Q000187:drug effects / Q000378:metabolism; D005260:Female; D016174:Hepacivirus / Q000187:drug effects* / Q000302:isolation & purification; D019698:Hepatitis C, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009367:Neoplasm Staging; D010094:Oxonic Acid / Q000008:administration & dosage; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000097:blood; D011960:Receptors, Estrogen / Q000097:blood; D005641:Tegafur / Q000008:administration & dosage; D000068878:Trastuzumab
chemical_list: D000730:Androstadienes; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D015415:Biomarkers; D014408:Biomarkers, Tumor; D004338:Drug Combinations; D066246:ErbB Receptors; D010094:Oxonic Acid; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D005641:Tegafur; D000068878:Trastuzumab; C079198:S 1 (combination); C508053:ERBB2 protein, human; C056516:exemestane